Advertisement

Topics

Inotrem S.A. Company Profile

09:50 EST 16th November 2018 | BioPortfolio

Inotrem is a biotechnology company specialized in the control of excessive immune response that occurs in acute inflammatory syndromes in the critical care setting. It has developed a new concept of immunomodulation to control abnormal immune response to tissue injuries, using a personalized medicine approach. The Company has been founded in 2013 in Nancy by Dr. Jean-Jacques Garaud, a former head of research and early development at the Roche Group, Prof. Sébastien Gibot and Dr. Marc Derive.


News Articles [5 Associated News Articles listed on BioPortfolio]

Inotrem reports positive data from Phase IIa trial of nangibotide

Inotrem has reported positive results from a Phase IIa trial of nangibotide (LR12) for the treatment of septic shock patients....Read More... The post Inotrem reports positive data from Phase IIa tria...

Inotrem’s nangibotide yields positive results in septic shock phase IIa study

The results were presented today at the annual congress of the International Sepsis Forum in Bangkok. Septic shock is the ultimate complication of sepsis and currently constitutes an The post Inotrem...

Inotrem reports 'favorable' markers for septic shock candidate

Inotrem Announces Positive Results From the Phase IIa Study of Its Lead Compound, Nangibotide (LR12), in the Treatment of Septic Shock

The study demonstrated the safety and tolerability of its lead compound in patients suffering from septic shock Inotrem S.A., a biotechnology focused on the ...

Septic Shock Drug Shows Promise for Personalized Medicine

Septic shock may no longer be as shocking in the future, as a Phase IIa trial brings hope for a personalized immunomodulatory treatment from the French biotech Inotrem.   In sepsis, the immune system...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Inotrem S.A.

Inotrem is a biotechnology company specialized in the control of excessive immune response that occurs in acute inflammatory syndromes in the critical care setting. It has develop...

Inotrem

More Information about "Inotrem S.A." on BioPortfolio

We have published hundreds of Inotrem S.A. news stories on BioPortfolio along with dozens of Inotrem S.A. Clinical Trials and PubMed Articles about Inotrem S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inotrem S.A. Companies in our database. You can also find out about relevant Inotrem S.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record